In LGG, this is the first report of TP53 mutation being a favourable prognostic factor, although this was reported previously in other cancers, including glioblastoma [93,94], sarcomas [95], ovarian serous cystadenocarcinoma [96] and cervical cancer [97]. Here, TP53 is linked to cervical carcinoma.